FeesSafety
Pluang+

LanzaTech sets Q3 2026 earnings release for Nov 16 with a conference call scheduled.

Company Fundamentals
29 Oct 2026, 14:15 WIB
GlobeNewsWire
View Source
Neutral
LanzaTech sets Q3 2026 earnings release for Nov 16 with a conference call scheduled.

LanzaTech announced it will release its third quarter 2026 financial results on November 16, 2026, before U.S. markets open. A conference call to discuss the results will follow at 8:30 a.m. Eastern Time, accessible via webcast and phone. This update is important for investors tracking the company's progress in carbon management technology and its commercial growth. The webcast replay will be available until November 30, 2026.

LanzaTech's upcoming third quarter 2026 earnings release offers context for readers. For those following Industrials-sector stocks on Pluang as of Oct 29, 2026 17:53 WIB, 76 of 135 stocks rose while 57 fell. Notable movers include INIO at USD 17.42 with a 5.07% decline and 100% sell order activity, BE at USD 218.20 down 4.33% with 82% sell orders, and AGCO at USD 98.00 down 4.07% but with 100% buy order activity and a typical hold time of 97 days.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App